Wells Fargo
ZEPP

Wells Fargo’s Zepp Health ZEPP Stock Holding History

Wells Fargo’s Portfolio ZEPP Stock Details ZEPP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$683 Buy
131
+56
+75% +$586 ﹤0.01% 6490
2026
Q1 		$896 Hold
75
– – ﹤0.01% 6353
2025
Q4 		$2.02K Buy
+75
New +$2.67K ﹤0.01% 6224
2024
Q3 		– Sell
-188
Closed -$450 – 7107
2024
Q2 		$450 Hold
188
– – ﹤0.01% 6154
2024
Q1 		$765 Hold
188
– – ﹤0.01% 6212
2023
Q4 		$1.06K Hold
188
– – ﹤0.01% 6208
2023
Q3 		$863 Hold
188
– – ﹤0.01% 6234
2023
Q2 		$855 Hold
188
– – ﹤0.01% 6357
2023
Q1 		$983 Buy
+188
New +$1.33K ﹤0.01% 6389
2022
Q4 		– Sell
-264
Closed -$1K – 7775
2022
Q3 		$1K Sell
264
-250
-49% -$1.81K ﹤0.01% 6486
2022
Q2 		$4K Sell
514
-89,726
-99% -$826K ﹤0.01% 6120
2022
Q1 		$1.04M Hold
90,240
– – ﹤0.01% 3849
2021
Q4 		$1.82M Sell
90,240
-1,457,422
-94% -$43.7M ﹤0.01% 3593
2021
Q3 		$49.7M Buy
1,547,662
+16,250
+1% +$671K 0.01% 1063
2021
Q2 		$71.9M Buy
1,531,412
+103,769
+7% +$4.32M 0.02% 846
2021
Q1 		$61.5M Sell
1,427,643
-105,500
-7% -$6.13M 0.01% 941
2020
Q4 		$72.7M Sell
1,533,143
-6,933
-0.5% -$346K 0.02% 789
2020
Q3 		$79.2M Sell
1,540,076
-15,150
-1% -$832K 0.02% 658
2020
Q2 		$76.9M Sell
1,555,226
-2,216
-0.1% -$102K 0.02% 655
2020
Q1 		$81.7M Buy
1,557,442
+10,190
+0.7% +$551K 0.03% 539
2019
Q4 		$74.4M Buy
1,547,252
+100,916
+7% +$4.23M 0.02% 723
2019
Q3 		$57.9M Buy
1,446,336
+116,521
+9% +$4.89M 0.02% 824
2019
Q2 		$53.2M Buy
1,329,815
+441,582
+50% +$18.4M 0.02% 881
2019
Q1 		$46.5M Buy
888,233
+83,727
+10% +$4.52M 0.01% 932
2018
Q4 		$31.6M Buy
804,506
+3,750
+0.5% +$147K 0.01% 1088
2018
Q3 		$34.3M Buy
800,756
+12,453
+2% +$501K 0.01% 1160
2018
Q2 		$31.1M Buy
788,303
+56,026
+8% +$2.3M 0.01% 1201
2018
Q1 		$31.1M Buy
+732,277
New +$32.5M 0.01% 1166

Other funds holding ZEPP

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $291M AUM 19.43% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $83.9B AUM 60.43% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo's ZEPP Position: Q2 2026 in Review

Wells Fargo increased its Zepp Health (ZEPP) stake by 75% in Q2 2026, buying an estimated $586 and bringing the position to 131 shares worth $683. The position accounts for ﹤0.01% of the portfolio, ranked #6490.

Wells Fargo first reported a position in ZEPP in Q1 2018 and has held it in 28 quarters since. The position peaked at $81.7M in Q1 2020. 28 funds tracked by Wall St. Rank hold ZEPP as of Q2 2026.

  • Wells Fargo held 131 shares of Zepp Health worth $683 as of Q2 2026.
  • Wells Fargo bought 56 Zepp Health shares in Q2 2026, an estimated $586.
  • Zepp Health made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6490 holding.
  • Wells Fargo first reported a position in Zepp Health in Q1 2018 and has held it in 28 quarters since.
  • Wells Fargo's Zepp Health position peaked at $81.7M in Q1 2020.
  • 28 funds tracked by Wall St. Rank held Zepp Health as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.